Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Bullboard Post History

by drdoctor7


T.NRI

Wow!

0 stars

Huge Concern #1: The approval of Pennsaid 2% is a major factor for NRI...

May 23, 2013

T.NRI

RE: RE: RE: RE: nice --

0 stars

Lots of reasons to be optimistic! If the trend continues, in another 10 - 14...

May 14, 2013

T.NRI

R/S

0 stars

Was on service the past week and didn't have the chance to wade through all...

May 9, 2013

T.NRI

RE: RE: European Launch

0 stars

Along those lines: http://www.theglobeandmail.com/report-on-business/industry...

April 24, 2013

T.NRI

European Launch

0 stars

A lot of excitement demonstrated with the European launch - almost $500...

April 24, 2013

T.NRI

European Launch

0 stars

A lot of excitement demonstrated with the European launch - almost $500...

April 24, 2013

T.NRI

Pliaglis

0 stars

What's the scoop on the Pliaglis launch? It apparently happened, but I hear...

April 16, 2013

T.NRI

Pliaglis

0 stars

What's the scoop on the Pliaglis launch? It apparently happened, but I hear...

April 16, 2013

T.NRI

RE: RE: Results published ------------------------

0 stars

A common theme, year after year. We will not hear of any significant news for...

March 27, 2013

T.NRI

RE: Delay in announcing Q4 results...

0 stars

Concerning. The last Canadian company that recently had some significant...

March 15, 2013

T.NRI

RE: RE: RE: RE: Retained Samples

0 stars

Consultant, I'll give them a call after the meeting. I am hoping that these...

March 6, 2013

T.NRI

Retained Samples

0 stars

A lot of questions given the pharmcokinetic decision. From the text, it is...

March 5, 2013

T.NRI

Denied!

0 stars

Further pharmacokinetic study required, but Mallinckrodt is a willing player!...

March 5, 2013

T.NRI

RE: Expectations.......?

0 stars

Good question.  First, I would really be surprised if the decision date will...

February 28, 2013

T.NRI

RE: RE: RE: RE: NRI: What's the downside? Whats th

0 stars

You bring up many good points on Synera. I agree that Endo’s marketing of two...

February 28, 2013

T.NRI

RE: NRI: What's the downside? Whats the upside?

0 stars

"continue to grow profitability with increasing revenue from Pennsaid classic...

February 27, 2013

T.NRI

RE: What are the odds of getting FDA approval...

0 stars

Good question Consultant. I strongly believe that Pennsaid 2% will be...

February 27, 2013

T.NRI

RE: RE: RE: I want to believe ...

0 stars

The clinical trial of 259 patients involved BID dosing. Hence, I would be...

February 18, 2013

T.NRI

Sales force for Pliaglis

0 stars

For small pharma, I often check on Cafepharma in hopes to get a sense on how...

February 16, 2013

T.NRI

RE: RE: Pennsaid safety questioned?

0 stars

Interesting article with a rather unexpected finding. One would expect NSAIDs...

February 16, 2013

1 2 Next